Mail

UK markets closed

FTSE 100
8,146.86
-16.81(-0.21%)
FTSE 250
20,120.36
-75.59(-0.37%)
AIM
776.04
-4.39(-0.56%)
GBP/EUR
1.1845
-0.0034(-0.29%)
GBP/USD
1.2686
-0.0074(-0.58%)
Bitcoin GBP
52,193.21
-47.17(-0.09%)

How I founded Britain's most respected removals firm

'Doing removals defines you for the rest of your working life'

Landfar Bio-medicine Co., Ltd (000504.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY

Add to watchlist

7.01

-0.22

(-3.04%)

At close: 03:04PM CST

Currency in CNY

Valuation measures⁴

Market cap (intra-day)	2.31B
Enterprise value	2.04B
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	17.36
Price/book (mrq)	9.10
Enterprise value/revenue	15.95
Enterprise value/EBITDA	-2.33k

Trading information

Stock price history

Beta (5Y monthly)	0.65
52-week change ³	-39.88%
S&P500 52-week change ³	23.76%
52-week high ³	12.37
52-week low ³	5.26
50-day moving average ³	7.46
200-day moving average ³	9.67

Share statistics

Avg vol (3-month) ³	6.97M
Avg vol (10-day) ³	6.64M
Shares outstanding ⁵	330.02M
Implied shares outstanding ⁶	330.02M
Float ⁸	149.39M
% held by insiders ¹	24.22%
% held by institutions ¹	24.42%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	23 Apr 2004
Last split factor ²	13:10
Last split date ³	15 Jan 2007

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	-22.63%
Operating margin (ttm)	-13.63%

Management effectiveness

Return on assets (ttm)	-4.32%
Return on equity (ttm)	-26.20%

Income statement

Revenue (ttm)	128.03M
Revenue per share (ttm)	0.40
Quarterly revenue growth (yoy)	-25.20%
Gross profit (ttm)	N/A
EBITDA	-37.22M
Net income avi to common (ttm)	-28.97M
Diluted EPS (ttm)	-0.09
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	313.15M
Total cash per share (mrq)	0.95
Total debt (mrq)	48.99M
Total debt/equity (mrq)	16.23%
Current ratio (mrq)	1.69
Book value per share (mrq)	0.77

Cash flow statement

Operating cash flow (ttm)	34.55M
Levered free cash flow (ttm)	21.28M